CTI BIOPHARMA CORP SEC filing history

1,000 loaded recent SEC filings. No local filings are indexed for this CIK yet. This fallback shows up to 1,000 recent submissions, not the complete SEC archive.

Open complete filing history at SEC

SEC filing history

Showing 351–375 of 1,000 matching filings.

Per page
25
Current page
15
4

OWNERSHIP DOCUMENT

Filing date
21 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
21 May 2018
Reporting date
21 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
17 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 May 2018
Reporting date
16 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-28386

DEF 14A

Filing date
30 Mar 2018
Reporting date
30 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
23 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-28386

PRE 14A

Filing date
21 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
07 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
28 Feb 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-48459

GROWTH EQUITY OPPORTUNITIES FUND V, LLC - CTI BIOPHARMA CORP. -- SCHEDULE 13D

Filing date
20 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 4 TO THE SCHEDULE 13D

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
12 Feb 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-221382

424B5

Filing date
12 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-221382

FWP

Filing date
09 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .